Protagenic Therapeutics, Inc.\new Net Income (Loss) Attributable to Noncontrolling Interest
Protagenic Therapeutics, Inc.\new (PTIX) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$1.00 thousand for the 3-month period ending 2015-12-31, per its 10-Q filed 2016-03-11.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2016-03-11
- Protagenic Therapeutics, Inc.\new net income (loss) attributable to noncontrolling interest for the quarter ending 2015-12-31 was -$1.00K.
- Protagenic Therapeutics, Inc.\new net income (loss) attributable to noncontrolling interest for the quarter ending 2015-09-30 was -$5.00K.
- Protagenic Therapeutics, Inc.\new net income (loss) attributable to noncontrolling interest for the quarter ending 2015-06-30 was -$5.00K.
- Protagenic Therapeutics, Inc.\new net income (loss) attributable to noncontrolling interest for the quarter ending 2015-03-31 was -$7.00K.
- Protagenic Therapeutics, Inc.\new net income (loss) attributable to noncontrolling interest for fiscal 2015 was -$25.00K.
- Protagenic Therapeutics, Inc.\new net income (loss) attributable to noncontrolling interest for fiscal 2014 was -$49.00K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2015-12-31 | -$1.00K 10-Q · filed 2016-03-11 | -$6.00K 10-Q · filed 2016-03-11 | -$11.00K derived: sum of 3 quarters · filed 2016-03-11 | -$18.00K derived: sum of 4 quarters · filed 2016-03-11 |
| 2015-09-30 | -$5.00K 10-Q · filed 2015-11-13 | -$10.00K derived: sum of 2 quarters · filed 2015-11-13 | -$17.00K derived: sum of 3 quarters · filed 2015-11-13 | -$23.00K derived: sum of 4 quarters · filed 2016-03-11 |
| 2015-06-30 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-25 | -$12.00K derived: sum of 2 quarters · filed 2015-09-25 | -$18.00K derived: sum of 3 quarters · filed 2016-03-11 | -$25.00K 10-K · filed 2015-09-25 |
| 2015-03-31 | -$7.00K 10-Q · filed 2015-05-11 | -$13.00K derived: sum of 2 quarters · filed 2016-03-11 | -$20.00K 10-Q · filed 2015-05-11 | -$34.00K derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-12-31 | -$6.00K 10-Q · filed 2016-03-11 | -$13.00K 10-Q · filed 2016-03-11 | -$27.00K derived: sum of 3 quarters · filed 2016-03-11 | -$38.00K derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-09-30 | -$7.00K 10-Q · filed 2015-11-13 | -$21.00K derived: sum of 2 quarters · filed 2015-11-13 | -$32.00K derived: sum of 3 quarters · filed 2015-11-13 | -$44.00K derived: sum of 4 quarters · filed 2015-11-13 |
| 2014-06-30 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-25 | -$25.00K derived: sum of 2 quarters · filed 2015-09-25 | -$37.00K derived: sum of 3 quarters · filed 2015-09-25 | -$49.00K 10-K · filed 2015-09-25 |
| 2014-03-31 | -$11.00K 10-Q · filed 2015-05-11 | -$23.00K derived: sum of 2 quarters · filed 2015-05-11 | -$35.00K 10-Q · filed 2015-05-11 | |
| 2013-12-31 | -$12.00K 10-Q · filed 2015-02-06 | -$24.00K 10-Q · filed 2015-02-06 | ||
| 2013-09-30 | -$12.00K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |